- Home
- BBAR vs PTGX Comparison
BBAR vs PTGX Comparison
Compare BBAR & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BBAR | PTGX |
|---|---|---|
| Founded | 1886 | 2006 |
| Country | Argentina | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 5.4B |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | BBAR | PTGX |
|---|---|---|
| Price | $17.46 | $80.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 9 |
| Target Price | $17.00 | ★ $93.00 |
| AVG Volume (30 Days) | 581.6K | ★ 909.6K |
| Earning Date | 11-25-2025 | 02-20-2026 |
| Dividend Yield | ★ 0.83% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.21 | ★ 0.72 |
| Revenue | ★ $1,535,146,865.00 | $209,217,000.00 |
| Revenue This Year | $0.64 | N/A |
| Revenue Next Year | $15.77 | $288.98 |
| P/E Ratio | ★ $29.70 | $114.23 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.76 | $33.70 |
| 52 Week High | $25.01 | $96.54 |
Technical Indicators
Market Signals| Indicator | BBAR | PTGX |
|---|---|---|
| Relative Strength Index (RSI) | 54.70 | 33.47 |
| Support Level | $17.61 | $84.11 |
| Resistance Level | $18.98 | $89.61 |
| Average True Range (ATR) | 0.83 | 3.13 |
| MACD | -0.15 | -1.18 |
| Stochastic Oscillator | 47.91 | 10.07 |
Price Performance
Historical ComparisonAbout BBAR Banco BBVA Argentina S.A. ADS
Banco BBVA Argentina SA is a banking services provider in Argentina. It provides financial assistance to large corporations, small and medium-sized companies, as well as individuals. It bank provides services through retail, corporate, investment banking, and Small and medium-sized companies divisions. Through the retail banking segment, it provides banking products and services to individuals, corporate banking deals with services to corporates, and the small and medium-sized companies segment focuses on foreign trade, agricultural business, and digital products.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.